Recently, other markers have been suggested for supporting the diagnosis of TFE3-rearranged renal cell carcinoma: TRIM63 detected by RNA in situ hybridization (RNA-ISH) [47] and GPNMB (glycoprotein nonmetastatic B) detected by immunohistochemistry [48]. The gene discussed is TFE3; the disease is renal cell carcinoma.